Yokohama, Japan

Jotaro Nakanishi

This inventor holds 3 USPTO granted patents and 4 published patent applications and 1 EPO patent. Top assignee: Shiseido Company, Limited. Active years: 1992-2015.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jotaro Nakanishi. Retrieved from https://idiyas.com/inventor/jotaro-nakanishi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 3 

% Patents Active = 100.0

 

Average Co-Inventor Count = 3.3

ph-index = 1

Forward Citations = 6(Granted Patents)


Company Filing History:


Years Active: 1992-2015

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Jotaro Nakanishi: Innovator in Pharmaceutical Research

Introduction

Jotaro Nakanishi is an inventor based in Yokohama-shi, Japan. He is known for his contributions to pharmaceutical research, particularly in the treatment of skin diseases and cancer. Although he currently holds no granted patents, his innovative ideas are reflected in his latest patent applications.

Latest Patent Applications

Nakanishi's latest patent applications include a method and pharmaceutical composition for treating psoriasis, squamous cell carcinoma, and/or parakeratosis by inhibiting the expression of squamous cell carcinoma-related antigen. This invention aims to provide a method for the treatment and prevention of diseases such as psoriasis and squamous cell carcinoma by targeting the expression of squamous cell carcinoma antigen (SCCA) in cells. Additionally, he has developed methods for enhancing the expression of intracellular redox-associated factors, utilizing active ingredients like kaempferol, quercetin, and ginkgo leaf extract.

Conclusion

Jotaro Nakanishi is a promising inventor whose latest patent applications showcase his dedication to advancing pharmaceutical treatments. His work has the potential to significantly impact the fields of dermatology and oncology.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…